Evolent Health, Inc.
EVH
$9.41
-$0.13-1.36%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 30.09% | 37.65% | 44.25% | 46.76% | 45.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.09% | 37.65% | 44.25% | 46.76% | 45.26% |
| Cost of Revenue | 45.49% | 53.59% | 56.05% | 53.49% | 45.20% |
| Gross Profit | -20.22% | -11.01% | 8.32% | 25.49% | 45.45% |
| SG&A Expenses | -16.26% | -22.37% | -10.06% | 10.24% | 22.35% |
| Depreciation & Amortization | -4.09% | 4.47% | 23.37% | 51.96% | 83.67% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.73% | 36.83% | 41.95% | 45.66% | 42.97% |
| Operating Income | -103.59% | 205.09% | 557.92% | 184.12% | 658.59% |
| Income Before Tax | 68.86% | 47.02% | 46.75% | 10.37% | -226.05% |
| Income Tax Expenses | 98.42% | 79.69% | 82.49% | 81.72% | -106.02% |
| Earnings from Continuing Operations | 45.49% | 20.60% | -17.14% | -231.02% | -504.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.49% | 20.60% | -17.14% | -226.48% | -489.86% |
| EBIT | -103.59% | 205.09% | 557.92% | 184.12% | 658.59% |
| EBITDA | -15.57% | 25.81% | 82.46% | 97.73% | 198.12% |
| EPS Basic | 36.14% | 10.93% | -32.47% | -224.72% | -531.22% |
| Normalized Basic EPS | 69.00% | 103.40% | 112.64% | 97.93% | -28.15% |
| EPS Diluted | 36.14% | 10.94% | -32.00% | -222.63% | -523.51% |
| Normalized Diluted EPS | 69.00% | 103.40% | 112.82% | 97.90% | -32.73% |
| Average Basic Shares Outstanding | 3.10% | 6.06% | 9.79% | 14.85% | 18.75% |
| Average Diluted Shares Outstanding | 3.10% | 6.06% | 8.74% | 13.69% | 17.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.96% | -0.89% | -1.04% | -0.70% | -- |
